Pure Cultures company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

purecultures2020.com

Stage

Acquired | Acquired

Total Raised

$350K

Revenue

$0000 

About Pure Cultures

Pure Cultures is a contract fermentation company that focuses on the production of probiotics. Pure Cultures develops and manufactures novel prebiotics and probiotics to support the animal health and eliminate antibiotics in our food chain.On November 13, 2020 Pure Cultures was acquired by CanBiocin. The terms of the transaction were not disclosed.

Pure Cultures Headquarter Location

2727 W 92nd Ave

Denver, Colorado, 80260,

United States

303-223-1663

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pure Cultures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pure Cultures is included in 1 Expert Collection, including Omics.

O

Omics

275 items

Latest Pure Cultures News

Canadian Pet and Livestock Probiotic Leader CanBiocin Expands into U.S. with Acquisition

Nov 13, 2020

has acquired all of the assets of Denver, CO based Pure Cultures Inc. effective April 30, 2020. CanBiocin produces species-specific probiotics to support pet and livestock health. Pure Cultures’ assets include proven species-specific probiotics, a U.S. patent for probiotics and fermentation metabolites for the prevention and treatment of disease conditions in animals as well as products for poultry and pigs marketed under the brand names Flock VitalityÒ and Pig Vitality™. Deal terms were not disclosed. “Pure Cultures’ founder and CEO Steve Kazemi has a shared vision and passion for improving pet and livestock health through enhanced nutrition backed by science and focusing on gut health,” said CanBiocin CEO Dr. J.F. (Jake) Burlet. “CanBiocin’s portfolio of species-specific probiotics support animal health by building health through the gut microbiome. The microbiome is the community of microorganisms residing in the intestinal tract and is responsible for digestion, metabolism, immune function and protecting against harmful bacteria,” says Burlet. This acquisition firmly establishes CanBiocin operations in the U.S.  Kazemi, a seasoned biotechnology veteran, joins CanBiocin as Chief Commercialization Officer. “Pure Cultures has made significant investments in developing novel products to develop a healthy gut,” said Kazemi. “Our focus has been developing natural alternatives to curb or eliminate the use of antibiotics in livestock while improving productivity.” CanBiocin successfully raised funds to close the transaction during the Covid-19 global pandemic; an unprecedented time of business uncertainty. “Our preparedness and willingness to explore all avenues for transaction funding allowed us to access the necessary liquidity for this deal,” stated Burlet. Around the world, people have leaned on their pets for comfort and companionship during extended periods of self-isolation. The importance of supporting and bolstering animal health for pet family members has never been more front and center. CanBiocin, together with an expanded suite of species-specific probiotics sourced via this asset purchase from Pure Cultures, has clearly positioned itself as a global leader with deep subject matter expertise in microbiome support,” said Dr. Burlet.

  • Where is Pure Cultures's headquarters?

    Pure Cultures's headquarters is located at 2727 W 92nd Ave, Denver.

  • What is Pure Cultures's latest funding round?

    Pure Cultures's latest funding round is Acquired.

  • How much did Pure Cultures raise?

    Pure Cultures raised a total of $350K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.